type here...

CATEGORIES

Patient Zone

LATEST

1...373839...59Page 38 of 59

TRENDING

EDITORS CHOICE

Aspirin. Your Heart’s Best Friend, or Maybe Not

Medika Life -
Aspirin is used by over 29 million Americans daily to prevent CVD and Stroke. New advice suggests we may want to rethink our use of the drug

The Ethics of A.I. in Healthcare Must Be Urgently Addressed

Robert Turner, Founding Editor -
A.I. is critical to the growth of healthcare in the coming decade. It needs to be managed correctly and urgent ethical guidelines regulating its use need to be implimented.

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Exclusive Medika Conversation with HIMSS Top Leadership – Inside Scoop on Key 2024 Priorities

Gil Bashe, Medika Life Editor -
HIMSS - World's top health IT society takes on pressing policy and patient care issues - AI, cybersecurity, info democratization and more are on the agenda!

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories